Request to partner

Request to attend

Call to action
Your text goes here. Insert your content, thoughts, or information in this space.
Button

Back to speakers

Jack
Geraats
Product Director Patient Solutions
SmartMed B.V.
Jack Geraats is Director of R&D and Product Director for Patient Solutions at SmartMed, bringing over 20 years of experience in software engineering, system architecture and healthcare innovation. Previously, Jack spent nearly 20 years at Philips, where he led multidisciplinary R&D teams and helped develop advanced healthcare platforms and oncology solutions. Passionate about translating emerging technologies into meaningful healthcare innovations, Jack focuses on advancing patient-centred solutions, personalised medicine and safer, more connected medication management.
Button
01 December 2026 11:30 - 12:15
What Should You Never Build? How product leaders decide where to invest and where to embed
The best product decisions aren't always about what to put on the roadmap. They're about what to take off it. For product leaders at software companies, one of the highest-leverage questions is: what is truly core to what we do, and what should we stop trying to own? In this session, we explore the build vs buy decision through two lenses. First, Jelte Jansons, a product leader turned product expert at Camunda, walks through the internal challenges most PMs face when navigating this question: managing stakeholder expectations, building the case for strategic shortcuts, and keeping engineering capacity focused on features that differentiate rather than foundations that commoditize. Then Jack Geraats, Product Leader of SmartMed, brings the theory to life. SmartMed's Care Manager, a care management product for patients with chronic conditions, runs on a workflow orchestration layer powered by Camunda. The decision to embed rather than build that layer freed SmartMed's team to focus entirely on the care experience. Jack shares how they made that call, what it meant for their roadmap, and what they would tell other product leaders facing the same question.